| NCT02338622 | Advanced Cancer | Phase 1 | Unknown | October 2015 | United Kingdom
... more >> Northern Institute for Cancer, Freeman Hospital
Recruiting
Newcastle, Newcastle upon Tyne, United Kingdom, NE7 7DN
Contact: Elizabeth R Plummer, MD +44(0)191 213844 ruth.plummer@newcastle.ac.uk
Principal Investigator: Elizabeth R Plummer, MD
Royal Marsden NHS Foundation Trust
Recruiting
Sutton, Surrey, United Kingdom, SM2 5PT
Contact: Timothy A Yap, PhD 0208 661 3539 timothy.yap@icr.ac.uk
Principal Investigator: Timothy A Yap, PhD Collapse << |
| NCT02015117 | Metastatic Malignant Neoplasm ... more >>in the Brain Collapse << | Phase 1 | Active, not recruiting | - | United States, Ohio
... more >>
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210 Collapse << |
| NCT02881242 | Hormone-Resistant Prostate Can... more >>cer
Metastatic Prostate Carcinoma
Recurrent Prostate Carcinoma
Stage IV Prostate Cancer Collapse << | Phase 2 | Recruiting | January 31, 2021 | United States, California
... more >>
UCLA / Jonsson Comprehensive Cancer Center
Recruiting
Los Angeles, California, United States, 90095
Contact: Matthew B. Rettig 310-794-3565 mrettig@mednet.ucla.edu
Principal Investigator: Matthew B. Rettig Collapse << |
| NCT01582997 | Cancer | Phase 1 | Completed | - | Japan
... more >> GSK Investigational Site
Shizuoka, Japan, 411-8777
GSK Investigational Site
Tokyo, Japan, 104-0045 Collapse << |
| NCT01324258 | Solid Tumours | Phase 1 | Completed | - | Japan
... more >> GSK Investigational Site
Osaka, Japan, 589-8511
GSK Investigational Site
Tokyo, Japan, 181-8611 Collapse << |
| NCT00880321 | Cancer | Phase 1 | Completed | - | United States, California
... more >>
GSK Investigational Site
Los Angeles, California, United States, 90025
United States, New York
GSK Investigational Site
New York, New York, United States, 10016
United States, Tennessee
GSK Investigational Site
Nashville, Tennessee, United States, 37203
United States, Texas
GSK Investigational Site
Houston, Texas, United States, 77030
Australia, New South Wales
GSK Investigational Site
Randwick, New South Wales, Australia, 2031
GSK Investigational Site
Westmead, New South Wales, Australia, 2145
Australia, South Australia
GSK Investigational Site
Adelaide, South Australia, Australia, 5000
Australia, Western Australia
GSK Investigational Site
Nedlands, Western Australia, Australia, 6009 Collapse << |
| NCT02065063 | Cancer | Phase 1 | Completed | - | United States, Massachusetts
... more >>
GSK Investigational Site
Boston, Massachusetts, United States, 02114
United States, Tennessee
GSK Investigational Site
Nashville, Tennessee, United States, 37232
United States, Texas
GSK Investigational Site
Houston, Texas, United States, 77030-4009 Collapse << |
| NCT03266159 | Solid Tumours | Phase 2 | Withdrawn(Study withdrawn befo... more >>re active to fully evaluate impact of changing practice in target population.) Collapse << | August 19, 2020 | - |
| NCT01072175 | Cancer | Phase 2 | Completed | - | United States, California
... more >>
Novartis Investigative Site
Los Angeles, California, United States, 90025
Novartis Investigative Site
San Francisco, California, United States, 94115
United States, Colorado
Novartis Investigative Site
Aurora, Colorado, United States, 80045
United States, Connecticut
Novartis Investigative Site
New Haven, Connecticut, United States, 06520
United States, Florida
Novartis Investigative Site
Tampa, Florida, United States, 33612
United States, Maryland
Novartis Investigative Site
Lutherville-Timonium, Maryland, United States, 21093
United States, Massachusetts
Novartis Investigative Site
Boston, Massachusetts, United States, 02114
Novartis Investigative Site
Boston, Massachusetts, United States, 02215
United States, Minnesota
Novartis Investigative Site
Rochester, Minnesota, United States, 55905
United States, Pennsylvania
Novartis Investigative Site
Philadelphia, Pennsylvania, United States, 19104
United States, Tennessee
Novartis Investigative Site
Nashville, Tennessee, United States, 37203
Novartis Investigative Site
Nashville, Tennessee, United States, 37232
United States, Texas
Novartis Investigative Site
Houston, Texas, United States, 77030-4009
Australia, New South Wales
Novartis Investigative Site
Westmead, New South Wales, Australia, 2145
Australia, Victoria
Novartis Investigative Site
Heidelberg, Victoria, Australia, 3084 Collapse << |
| NCT02314143 | Melanoma | Phase 2 | Completed | - | France
... more >> GSK Investigational Site
Bordeaux, France, 33075
GSK Investigational Site
Marseille cedex 5, France, 13385
GSK Investigational Site
Reims Cedex, France, 51092
GSK Investigational Site
Rennes Cedex, France, 35042
GSK Investigational Site
Villejuif cedex, France, 94805
Spain
GSK Investigational Site
Barcelona, Spain, 08036
GSK Investigational Site
Madrid, Spain, 28041 Collapse << |
| NCT01476137 | Cancer | Phase 1 | Completed | - | United States, Texas
... more >>
GSK Investigational Site
Dallas, Texas, United States, 75246
GSK Investigational Site
San Antonio, Texas, United States, 78229 Collapse << |
| NCT02281760 | BRAF V600E Mutation | Phase 2 | Completed | - | United States, Maryland
... more >>
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892 Collapse << |
| NCT01938443 | Cancer | Phase 1 | Completed | - | France
... more >> GSK Investigational Site
Villejuif Cedex, France, 94805
United Kingdom
GSK Investigational Site
London, United Kingdom, W12 0HS
GSK Investigational Site
London, United Kingdom, W1G 6AD
GSK Investigational Site
Newcastle upon Tyne, United Kingdom, NE7 7DN Collapse << |
| NCT01072175 | - | - | Completed | - | - |
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
